Background Device closure of atrial septal defect (ASD) and patent foramen ovale (PFO) are
both associated with short‐and long‐term complications. Our knowledge of the complication …

Background The Occlutech Figulla ASD device series (OFSO) shows an improved device
design for interventional ASD closure, larger follow‐up series are missing. Methods We …

Atrial septal defect (ASD) is the most common type of common congenital heart disease
(CHD) in adults. During the last decade, there has been a remarkable change in the …

Objectives: This study sought to determine institutional complication rates in a previously
underreported patient population and discuss referral indications. Background: There has …

Atrial septal defect (ASD) is the most common congenital cardiac lesion accounting for 10–
15% of all cardiac malformations. In the majority of cases, the secundum type of the ASD is …

Background: Atrial septal defect (ASD) type 2, according to current standards, is closed
percutaneously usually after the child has reached the age of four to five years. There are …

Device closure of atrial septal defect (ASD) is commonly performed in older children and
adults. Infants and toddlers (age< 4 years) are seldom referred for ASD closure due to size …

Objective. Device closure of secundum type atrial septal defects in young children has now
become common with extension of this practice to children less than 1 year of age. We …

Background This perspective, observational study evaluated safety and efficacy of the
GORE® Cardioform ASD Occluder (WL Gore & Associates, Flagstaff, AZ), compliant and …

Elective closure of atrial septal defect (ASD) is usually recommended during preschool
ages. However, ASD may contribute to deteriorating health in the presence of significant …